In January–August 2024, Russian manufacturers produced 530.7 billion rubles’ worth of finished pharmaceutical drugs (manufacturer’s prices, VAT included), up 16.7% from the same period in 2023.

Most Russian physicians believe that health facilities should have a dress code policy, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors.

In January–August 2024, the average receipt in Russian pharmacies was 688 rubles, up 12% from the same period in 2023. Pharmaceutical drugs account for over 80% of the receipt, contributing to the growth rates.

In January–August 2024, the average receipt in Russian pharmacies was 688 rubles, up 12% from the same period in 2023. Pharmaceutical drugs account for over 80% of the receipt, contributing to the growth rates.

In January–July 2024, over 25.5 billion rubles’ worth of veterinary drugs were sold on the Russian veterinary retail market (retail prices, VAT included), up 14.7% from January–July 2023.

In January–July 2024, veterinary drugs on the Russian retail market (e-com included) went up in price 31.8% from January–July 2023. The price index in 2023 was 26.6%.

In the first half of 2024, the Russian retail market of beauty fillers and biorevitalization products was 10.9 billion rubles (retail prices, VAT included), up 21% from January–June 2023.

In January–July 2024, Russia manufactured 462.5 billion rubles’ worth of finished pharmaceutical products (manufacturer’s prices, VAT included), up 16% from the same period last year. In physical terms, it was 2.37 billion packages, up 4.6% from January–July 2023.

Most Russian physicians support the initiative to ban migrants from working in Russian clinics, according to a survey conducted by the RNC Pharma analyst company and the Medvestnik platform for doctors.

In Q1–Q2 2024, the average receipt in the veterinary retail market was 734 rubles, up 9.2% from the same period in 2023. The average receipt in offline veterinary pharmacies was lower, 646 rubles.